Products for Research Use Only

Macupatide (acetate)

CAT: 0804-HY-P10959A-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P10959A-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Macupatide acetate is a gastric inhibitory peptide (GIP) receptor agonist used in anti-diabetic research[1].
Product Name Alternative
LY3532226 (acetate)
UNSPSC
12352209
Target
Insulin Receptor
Related Pathways
Protein Tyrosine Kinase/RTK
Field of Research
Metabolic Disease
Purity
99.71
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(NC(C(N[C@@H](CCC(O)=O)C(NCC(N[C@@H]([C@H](O)C)C(N[C@@H](CC1=CC=CC=C1)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CO)C(N[C@@H](CC(O)=O)C(N[C@@H](CC2=CC=C(C=C2)O)C(N[C@@H](CO)C(N[C@@H]([C@@H](C)CC)C(N[C@](C(N[C@@H](CC(C)C)C(N[C@@H](CC(O)=O)C(N[C@@H](CCCCN)C(N[C@@H](CCCCNC(COCCOCCNC(COCCOCCNC(CC[C@H](NC(CCCCCCCCCCCCCCCCCCC(O)=O)=O)C(O)=O)=O)=O)=O)C(N[C@@H](CC3=CNC=N3)C(N[C@@H](CCC(N)=O)C(NC(C(N[C@@H](CC(O)=O)C(N[C@@H](CC4=CC=CC=C4)C(N[C@@H](C(C)C)C(N[C@@H](CCC(O)=O)C(N[C@@H](CC5=CC=NC=C5)C(N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CCC(O)=O)C(N[C@@H](C)C(NCC(N6[C@@H](CCC6)C(N[C@@H](CO)C(N[C@@H](CO)C(NCC(N[C@@H](C)C(N7[C@@H](CCC7)C(N8[C@@H](CCC8)C(N9[C@@H](CCC9)C(N[C@@H](CO)C(N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)(C)C)=O)=O)=O)=O)=O)=O)=O)(CC(C)C)C)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)(C)C)[C@H](CC%10=CC=C(C=C%10)O)N.CC(O)=O.[x]
Molecular Formula
C232H357N49O72.xC2H4O2
Molecular Weight
4984.60 (free base)
References & Citations
[1]Mari A, et al. Tirzepatide Treatment and Associated Changes in β-Cell Function and Insulin Sensitivity in People With Obesity or Overweight With Prediabetes or Normoglycemia: A Post Hoc Analysis From the SURMOUNT-1 Trial. Diabetes Care. 2025 Jul 22:dc250763.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported